Skip to main content

Advertisement

Fig. 4 | Clinical Proteomics

Fig. 4

From: Serum proteomic-based analysis identifying autoantibodies against PRDX2 and PRDX3 as potential diagnostic biomarkers in nasopharyngeal carcinoma

Fig. 4

ROC curve analysis of the combination of autoantibodies against PRDX2 and PRDX3, and VCA-IgA. a ROC curve for the combination of autoantibodies against PRDX2 and PRDX3, and VCA-IgA for patients with NPC versus normal controls. b ROC curve for the combination of autoantibodies against PRDX2 and PRDX3, and VCA-IgA for patients with early NPC versus normal controls. ROC receiver operating characteristic; NPC

Back to article page